Dow Up 0.76% Nasdaq Up 0.69%

Celgene Corporation (CELG)

-NasdaqGS
103.24 Up 2.84(2.83%) Oct 24, 3:59PM EDT
|After Hours : 103.30 Up 0.06 (0.06%) Oct 24, 7:59PM EDT
Prev Close:100.40
Open:99.50
Bid:101.84 x 100
Ask:103.45 x 200
1y Target Est:111.55
Beta:1.5
Next Earnings Date:N/A
Day's Range:99.21 - 103.31
52wk Range:66.85 - 103.31
Volume:9,131,573
Avg Vol (3m):4,734,500
Market Cap:82.54B
P/E (ttm):59.68
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
CELGUp 2.83%82.54B
JNJUp 0.49%290.86B

Key Statistics

Forward P/E (1 yr):21.11
P/S (ttm):11.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback